HMGB1 Protein Levels in Patients with Infections and Sepsis
Author Information
Author(s): Gaïni Shahin, Svend Stenvang, Ole Græsbøll Koldkjær, Court Pedersen, Holger Jon Møller
Primary Institution: Odense University Hospital
Hypothesis
The study aims to evaluate HMGB1 as a molecular marker in patients with community-acquired infections.
Conclusion
HMGB1 levels were significantly higher in patients with suspected infections compared to healthy controls, but did not differ significantly between infected and non-infected patients.
Supporting Evidence
- HMGB1 levels were significantly higher in patients compared to healthy controls.
- No significant difference in HMGB1 levels was found between infected and non-infected patients.
- HMGB1 correlated weakly with other pro-inflammatory markers.
Takeaway
Doctors looked at a protein called HMGB1 in sick patients to see if it could help tell if they had an infection. They found it was higher in sick people than in healthy ones, but it didn't help much in telling apart those who were infected from those who weren't.
Methodology
Patients suspected of having infections/sepsis were included in a prospective study, with various biological markers measured upon admission.
Potential Biases
There is a risk of imperfect gold-standard bias in classifying the patients' infection status.
Limitations
The study had a heterogeneous patient population and a low mortality rate, which may limit the generalizability of the findings.
Participant Demographics
The study included elderly patients with a considerable burden of comorbidity.
Statistical Information
P-Value
P < 0.001
Confidence Interval
95% CI 0.5 to 0.68
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website